September 7, 2020
The Pharmaceuticals and Medical Devices Agency (PMDA) is investigating new side effect risks for Takeda Pharmaceutical’s acid reducer Takecab (vonoprazan) and two other drugs, a move likely to trigger label changes in the near future. According to the risk communication...read more